Diceros Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $12.6M

  • Investors
  • 1

Diceros Therapeutics General Information

Description

Operator of a biopharmaceutical company developing a novel treatment for chronic rhinosinusitis intended to alleviate sinus pain and improve the quality of life for millions suffering from this condition. The company offers a patent-protected combination therapy designed to address the underlying inflammation and bacterial biofilm in chronic rhinosinusitis, aiming to provide patients with a safe, effective, and potentially curative alternative to current management options, enabling patients to experience lasting relief from chronic sinus symptoms and breathe easier.

Contact Information

Website
www.dicerostherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 275 Grove Street
  • Suite 2-400
  • Newton, MA 02466
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 275 Grove Street
  • Suite 2-400
  • Newton, MA 02466
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diceros Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Aug-2024 $12.6M Completed Clinical Trials - General
To view Diceros Therapeutics’s complete valuation and funding history, request access »

Diceros Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Diceros Therapeutics’s complete cap table history, request access »

Diceros Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pimlico Pond Investments Family Office Minority
To view Diceros Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Diceros Therapeutics FAQs

  • When was Diceros Therapeutics founded?

    Diceros Therapeutics was founded in 2022.

  • Where is Diceros Therapeutics headquartered?

    Diceros Therapeutics is headquartered in Newton, MA.

  • What industry is Diceros Therapeutics in?

    Diceros Therapeutics’s primary industry is Drug Discovery.

  • Is Diceros Therapeutics a private or public company?

    Diceros Therapeutics is a Private company.

  • What is the current valuation of Diceros Therapeutics?

    The current valuation of Diceros Therapeutics is .

  • What is Diceros Therapeutics’s current revenue?

    The current revenue for Diceros Therapeutics is .

  • How much funding has Diceros Therapeutics raised over time?

    Diceros Therapeutics has raised $12.6M.

  • Who are Diceros Therapeutics’s investors?

    Pimlico Pond Investments has invested in Diceros Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process